What perimenopause actually is — the hormonal mechanism

Perimenopause begins when ovarian reserve — the number of viable eggs remaining in the ovaries — starts to decline meaningfully. Women are born with all the eggs they will ever have, approximately one to two million. By puberty, that number has fallen to around 300,000. By the late 30s and early 40s, the pool is shrinking rapidly enough that the ovaries begin to respond less reliably to the hormonal signals from the brain that orchestrate the cycle.

The hypothalamus and pituitary continue sending their signals — FSH (follicle stimulating hormone) and LH (luteinising hormone) — but the ovaries respond with increasing irregularity. Some months, follicular development is normal and estrogen production is adequate. Other months, follicles develop partially but do not ovulate, producing estrogen without the progesterone that ovulation provides. This estrogen-without-progesterone pattern is one of the defining hormonal features of early perimenopause — and the source of many of its earliest symptoms.

When does perimenopause start?
Perimenopause typically begins between 40 and 44, though it can start as early as the mid-30s. The average age of onset is 47, with the full transition to menopause occurring on average at 51 to 52. The duration varies from 2 to 10 years and is influenced by genetics, lifestyle, body composition and stress history.

The hormone changes — in order, and what each one means

Progesterone falls first. Because progesterone is produced after ovulation, and ovulation becomes less reliable in early perimenopause, progesterone is the first hormone to decline meaningfully. This is counterintuitive to most women — who associate perimenopause with estrogen loss — but it is the clinical reality. Low progesterone in the luteal phase produces a recognisable cluster of symptoms: heavier periods, worsening PMS, sleep disruption (progesterone has a sedative effect), anxiety and mood instability. Read more about low progesterone and its symptoms.

Estrogen becomes erratic before it falls. In early perimenopause, estrogen does not simply decline — it fluctuates wildly. Months of relative estrogen excess (when follicles develop but do not ovulate) can alternate with months of relative deficiency. This volatility — not the eventual decline — is responsible for many of perimenopause's most disruptive symptoms. Hot flushes, for example, are driven by rapid fluctuations in estrogen rather than by low estrogen per se — they are the body's thermoregulatory system responding to hormonal instability.

Testosterone declines gradually. Ovarian testosterone production declines through perimenopause and beyond. Testosterone in women supports libido, energy, cognitive sharpness, muscle mass maintenance and mood. Its decline is often gradual enough to go unnoticed until the cumulative effect becomes apparent — typically as reduced libido, physical fatigue or the loss of the motivational quality that characterised earlier adult life.

FSH rises. As the ovaries become less responsive, the pituitary produces more and more FSH in an attempt to stimulate them. Elevated FSH is a clinical marker of declining ovarian reserve and is often used diagnostically — though a single FSH reading is unreliable given the hormonal fluctuation of perimenopause. A consistently elevated FSH across multiple readings is more meaningful.

What are the first signs of perimenopause?
The earliest signs are often subtle and frequently misattributed to stress. They include changes in cycle length or flow, new or worsening PMS, sleep disruption — particularly waking in the early hours — increased anxiety or low mood, brain fog, and decreased libido. Hot flushes, the symptom most commonly associated with perimenopause, often appear later in the transition, not at the beginning.

Why symptoms feel so wide-ranging — the estrogen receptor explanation

The reason perimenopause produces such a bewildering variety of symptoms is that estrogen receptors are found throughout the body — not just in reproductive tissue. The brain, heart, bones, gut lining, skin, urinary tract, immune system and cardiovascular system all contain estrogen receptors. As estrogen fluctuates and eventually falls, every one of these systems is affected.

This is why a woman in perimenopause might experience joint pain (estrogen has anti-inflammatory effects on joints), urgency incontinence (estrogen maintains the integrity of bladder and urethral tissue), palpitations (estrogen influences heart rate variability), and changes in gut motility (estrogen receptors in the gut affect transit time) — in addition to the more discussed symptoms of hot flushes and mood changes. These are not separate problems. They are the same hormonal shift expressing itself across different tissues.

Why does perimenopause cause so many different symptoms?
Estrogen receptors are found throughout the body — in the brain, heart, bones, gut, skin, urinary tract, and immune system. As estrogen fluctuates and eventually declines in perimenopause, every tissue that depends on it is affected. Hot flushes, brain fog, joint pain, urinary urgency, palpitations, and mood changes are all downstream effects of the same hormonal shift.
Perimenopause is not the end of something. It is a hormonal transition — and like every hormonal transition in a woman's life, understanding it is the first step to moving through it with intention rather than confusion.

What you can do — the evidence-based foundations

Strength training. Muscle mass declines accelerate in perimenopause as estrogen falls. Strength training is the single most important lifestyle intervention for maintaining muscle, bone density, metabolic health and insulin sensitivity through the transition — and beyond. Two to three sessions per week of progressive resistance training is the minimum meaningful dose. Read more about hormones and muscle gain in women.

Protein. Protein requirements increase in perimenopause and post-menopause. The anabolic signalling that estrogen supported must increasingly be replaced by dietary protein and resistance training. 1.6 to 2g of protein per kilogram of body weight daily is the evidence-based target for perimenopausal women seeking to maintain or build lean mass.

Sleep. Progesterone's sedative effect is lost in perimenopause, and estrogen fluctuations disrupt the temperature regulation that underlies deep sleep. Sleep hygiene interventions take on new urgency — consistent sleep and wake times, cool room temperature, limiting alcohol (which fragments sleep architecture significantly), and addressing hot flushes with clinical support if they are disruptive.

Creatine. One of the most evidence-backed supplements for perimenopausal women — supporting muscle energy metabolism, cognitive function and mood in the period when estrogen can no longer fill those roles. Read more about creatine for women and hormonal health.

Hormone therapy. Menopausal hormone therapy (MHT, formerly HRT) has been significantly rehabilitated by modern research. The risks that caused widespread abandonment in the early 2000s were overstated and specific to older, synthetic formulations. Body-identical hormone therapy — estradiol via transdermal patch or gel, with micronised progesterone — has a very different risk profile and meaningful benefits for quality of life, bone density, cardiovascular health and cognitive function when started within 10 years of the final period. This is a conversation for your clinician, but it deserves to be a conversation — not an assumption that it is unavailable or inadvisable.

Is perimenopause the same as menopause?
No. Perimenopause is the transition period leading up to menopause — typically lasting 4 to 10 years — during which ovarian function declines and hormones fluctuate irregularly. Menopause is a single point in time: 12 consecutive months without a menstrual period. Most of the symptoms commonly associated with menopause — including hot flushes, sleep disruption and mood changes — actually begin during perimenopause, often years before the final period.